Article
Targeted Therapy and Immunotherapy for Lung Cancer.
Surgical oncology clinics of North America - 1 Jul 2016
Naylor Evan C, Desani Jatin K, Chung Paul K
Abstract excerpt
Targeted therapy and immunotherapy have changed the treatment paradigm of non-small cell lung cancer (NSCLC). Distinct molecular subtypes of NSCLC have been described over the past 20 years, enabling the emergence of treatments specific to that subtype. Agents targeting the driver mutations in NSCLC have revolutionized the approach to patients with metastatic disease, because oncologists now select a treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
